Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NYXH

Nyxoah SA

May 26 • 04:00PM ET

2.70

-0.17 -5.92 %

Healthcare • Medical Instruments & Supplies • Belgium • Micro • NASD

Peers: INSP NPCE RMD PHG LIVN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.47	Insider Own	45.76%	Shs Outstand	43.66M	Perf Week	-7.53%
Market Cap	120.66M	Forward P/E	-	EPS next Y	-1.34	Insider Trans	0.00%	Shs Float	24.24M	Perf Month	-9.40%
Enterprise Value	132.35M	PEG	-	EPS next Q	-0.48	Inst Own	8.86%	Short Float	1.35%	Perf Quarter	-36.78%
Income	-96.93M	P/S	6.76	EPS this Y	35.79%	Inst Trans	-6.02%	Short Ratio	6.19	Perf Half Y	-40.66%
Sales	17.85M	P/B	2.85	EPS next Y	23.62%	ROA	-74.78%	Short Interest	0.33M	Perf YTD	-41.30%
Book/sh	0.95	P/C	4.04	EPS next 5Y	30.60%	ROE	-136.89%	52W High	8.59 -68.56%	Perf Year	-65.12%
Cash/sh	0.67	P/FCF	-	EPS past 3/5Y	-28.04% -28.17%	ROIC	-153.64%	52W Low	2.72 -0.74%	Perf 3Y	-65.82%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	51.67% 170.10%	Gross Margin	25.35%	Volatility	4.70% 4.83%	Perf 5Y	-88.34%
Dividend TTM	-	EV/Sales	7.41	EPS Y/Y TTM	-16.22%	Oper. Margin	-549.51%	ATR (14)	0.18	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.86	Sales Y/Y TTM	280.71%	Profit Margin	-543.13%	RSI (14)	37.19	Recom	1.75
Dividend Gr. 3/5Y	- -	Current Ratio	0.97	EPS Q/Q	31.44%	SMA20	-9.89%	Beta	1.59	Target Price	9.28
Payout	-	Debt/Eq	1.01	Sales Q/Q	565.71%	SMA50	-12.09%	Rel Volume	0.75	Prev Close	2.87
Employees	-	LT Debt/Eq	0.53	Earnings	May 12 AMC	SMA200	-41.02%	Avg Volume	52.68K	Price	2.70
IPO	Apr 28, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	26.38% 4.54%	Trades		Volume	39,684	Change	-5.92%

Date	Action	Analyst	Rating Change	Price Target Change
May-12-26	Downgrade	Stifel	Buy → Hold	$5
Jul-31-23	Initiated	H.C. Wainwright	Buy
Jul-19-23	Initiated	Robert W. Baird	Neutral
Apr-21-22	Initiated	Oppenheimer	Outperform	$30
Apr-06-22	Initiated	Wolfe Research	Peer Perform	$21
Dec-21-21	Resumed	Cantor Fitzgerald	Overweight	$47
Jul-28-21	Initiated	Cantor Fitzgerald	Overweight	$43

May-20-26 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
04:05PM	Nyxoah Welcomes the Flemish Investors Federation (VFB) at LegiaPark following Q1 2026 Results and U.S. Commercial Momentum (GlobeNewswire)
May-13-26 01:01AM	Nyxoah SA (NYXH) Q1 2026 Earnings Call Highlights: Strong U.S. ... (GuruFocus.com)
May-12-26 04:05PM	Nyxoah Reports First Quarter 2026 Financial and Operating Results (GlobeNewswire) -7.81%
May-11-26 09:22AM	Nyxoah SA (XBRU:NYXH) Q1 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
04:05PM	Loading…
May-08-26 04:05PM	Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 10, 2026 (GlobeNewswire)
Apr-30-26 04:05PM	Nyxoah to Participate in the Bank of America 2026 Healthcare Conference (GlobeNewswire)
Apr-28-26 04:05PM	Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 (GlobeNewswire)
Mar-20-26 05:30PM	Publication relating to transparency notifications (GlobeNewswire)
01:00AM	Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges (GuruFocus.com)
Mar-19-26 04:10PM	Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results (GlobeNewswire)
Mar-18-26 09:22AM	Earnings To Watch: Nyxoah SA (XBRU:NYXH) Reports Q4 2025 Result (GuruFocus.com)
Mar-13-26 05:30PM	Publication relating to transparency notification (GlobeNewswire) -8.99%
Mar-11-26 05:05PM	Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference (GlobeNewswire)
Mar-05-26 04:05PM	Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 (GlobeNewswire) -5.58%
05:55PM	Loading…
Mar-04-26 05:55PM	Veeva Systems (VEEV) Q4 Earnings and Revenues Surpass Estimates (Zacks) +5.07%
Feb-27-26 04:30PM	Publication relating to transparency notifications (GlobeNewswire) -13.19%
Feb-25-26 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire) +5.62%
Feb-18-26 04:05PM	Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East (GlobeNewswire) +8.69%
Jan-21-26 04:05PM	Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth (GlobeNewswire)
Jan-12-26 04:05PM	Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026 (GlobeNewswire)
01:00AM	Publication relating to transparency notification (GlobeNewswire)
Dec-29-25 04:05PM	Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +6.26%
Dec-19-25 04:05PM	Nyxoah Announces Issuance of First Tranche of Convertible Bonds (GlobeNewswire)
Dec-17-25 01:05AM	Nyxoah Announces Commercial Launch of Genio Breakthrough Therapy in the Netherlands (GlobeNewswire)
Dec-02-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire) -5.42%
Dec-01-25 09:14AM	Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System (Zacks)
Nov-27-25 04:05PM	Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 01:45AM	Nyxoah's Genio Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule (GlobeNewswire)
Nov-23-25 08:00PM	Nyxoah SA (NYXH) Q3 2025 Earnings Call Highlights: Strong US Launch and Strategic Expansion ... (GuruFocus.com)
04:30PM	Loading…
Nov-20-25 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Nov-13-25 07:30PM	Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio (GlobeNewswire) -9.85% -5.84%
05:55PM	Nyxoah SA (NYXH) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:12PM	Nyxoah Reports Third Quarter 2025 Financial and Operating Results (GlobeNewswire)
Nov-12-25 07:30AM	Nyxoah SA (XBRU:NYXH) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-06-25 07:15AM	Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates (Zacks)
Nov-03-25 04:05PM	Nyxoah to Participate in the Stifel 2025 Healthcare Conference (GlobeNewswire)
Oct-30-25 05:10PM	Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025 (GlobeNewswire)
10:00AM	10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-29-25 10:00AM	Analysts Estimate Nyxoah SA (NYXH) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-07-25 12:30PM	Nyxoah Shares Rise on First U.S. Commercial Use of Genio System (Zacks) +12.41%
Oct-06-25 01:00AM	Nyxoah Announces First U.S. Commercial Patients Implanted with Genio System (GlobeNewswire) +17.17%
Oct-03-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Oct-02-25 09:10AM	Nyxoah Expands in the Middle East to Provide Wider Access to Genio (Zacks)
Sep-23-25 04:10PM	Nyxoah Provides an Update on Expanded Middle East Presence (GlobeNewswire)
Sep-15-25 04:10PM	Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc. (GlobeNewswire) -8.97%
Sep-05-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Sep-02-25 04:30PM	Nyxoah Announces Upcoming Investor Events (GlobeNewswire) -5.45%
Aug-29-25 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Aug-18-25 04:10PM	Nyxoah Reports Second Quarter Financial and Operating Results (GlobeNewswire) +5.63%
Aug-15-25 10:10AM	Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea (Zacks) -8.53%
09:18AM	Nyxoah SA (NYXH) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Aug-11-25 07:00PM	Standard BioTools (LAB) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.39%
01:00AM	Nyxoah Announces Preliminary Results for the Second Quarter of 2025 (GlobeNewswire)
Aug-08-25 04:10PM	Nyxoah Receives Approval from FDA for Genio System for the Treatment of Obstructive Sleep Apnea (GlobeNewswire)
Aug-07-25 07:10AM	Privia Health (PRVA) Misses Q2 Earnings Estimates (Zacks)
Aug-06-25 05:55PM	Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Jul-29-25 04:45PM	Information on the total number of voting rights and shares (GlobeNewswire)
04:30PM	Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 (GlobeNewswire)
Jul-28-25 04:05PM	Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine (GlobeNewswire) -5.41%
Jun-27-25 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Jun-13-25 01:00AM	Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025 (GlobeNewswire)
May-30-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
May-28-25 04:30PM	Nyxoah to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-23-25 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire) -6.97%
May-14-25 07:35AM	Nyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
01:00AM	Nyxoah Reports First Quarter Financial and Operating Results (GlobeNewswire)
May-09-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire) -5.08%
01:00AM	Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025 (GlobeNewswire)
May-08-25 07:15AM	Claritev Corporation (CTEV) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-07-25 05:15PM	Health Catalyst (HCAT) Q1 Earnings Meet Estimates (Zacks)
04:30PM	Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 (GlobeNewswire)
May-06-25 05:55PM	Clover Health Investments, Corp. (CLOV) Surpasses Q1 Earnings Estimates (Zacks)
Apr-16-25 02:00AM	Conditional Issuance of Shares (GlobeNewswire)
Apr-08-25 01:00AM	Nyxoah Provides Update on FDA Approvable Letter for Genio System (GlobeNewswire) +6.13%
Mar-26-25 03:00AM	FDA Issues Nyxoah an Approvable Letter for its Genio System (GlobeNewswire) -21.36%
Mar-13-25 02:00AM	Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results (GlobeNewswire)
Mar-10-25 05:05PM	Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 (GlobeNewswire)
Mar-03-25 04:30PM	Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference (GlobeNewswire)
Feb-19-25 01:05AM	Nyxoah Announces Commercial Launch of Genio Breakthrough Therapy in the Middle East (GlobeNewswire)
Jan-20-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Dec-20-24 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Dec-13-24 02:05AM	Nyxoah Announces Commercial Launch of Genio Innovative Therapy in England (GlobeNewswire)
Nov-27-24 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Nov-20-24 04:05PM	Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-19-24 01:00AM	Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024 (GlobeNewswire)
Nov-18-24 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Nov-06-24 04:05PM	Nyxoah Reports Third Quarter Financial and Operating Results (GlobeNewswire)
Nov-04-24 04:45PM	Nyxoah Appoints John Landry as Chief Financial Officer (GlobeNewswire) +5.40%
Oct-25-24 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Oct-22-24 04:30PM	Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 (GlobeNewswire)
Oct-15-24 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Oct-09-24 04:35PM	Information on the total number of voting rights and shares (GlobeNewswire)
04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Oct-08-24 05:49PM	Nyxoah Secures $27 Million to Boost U.S. Presence (TipRanks)
Oct-07-24 05:00PM	Nyxoah Raises $27 Million through its At-the-Market Offering (GlobeNewswire)
Sep-27-24 04:30PM	DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update (GlobeNewswire) +5.56%
02:05AM	Information on the total number of voting rights and shares (GlobeNewswire)
02:00AM	Publication relating to transparency notifications (GlobeNewswire)
Sep-05-24 04:30PM	Nyxoah to Participate in Upcoming Investor Conferences (GlobeNewswire)

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.

Co-Founder & ChairmanMr. Robert Taub MBA

CEO & Executive DirectorMr. Olivier Taelman

Chief Technical OfficerMr. Bruno Onkelinx

Chief Financial OfficerMr. John Landry

Chief Science OfficerMr. Jeyakumar Subbaroyan

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NYXH

Nyxoah SA

Upgrade your Finviz experience